Overview

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Exploratory, mono-center, randomized, intra-individual, controlled trial involving healthy volunteers to compare the effect on MAL penetration into the skin following various mechanical penetration enhancement techniques.
Phase:
Phase 1
Details
Lead Sponsor:
Galderma R&D
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate